Epidemiology of neuroimmunological diseases (Journal of Neurology (2006) 253, (SUPPL. 5) (2-8) DOI: 10.1007/s00415-006-5001-3);Epidemiology of neuroimmunological diseases

Journal of Neurology

Volumn 253, Issue SUPPL. 5, 2006, Pages 308-

  Flachenecker, Peter ^a  

^a Neurological Rehabilitation Center Quellenhof   (Germany)

Author keywords

Epidemiology; Guillain Barr syndrome; Inflammatory muscle diseases; MS register; Multiple sclerosis; Myasthenia gravis

Indexed keywords

ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; CRYOGLOBULINEMIA; DERMATOMYOSITIS; GIANT CELL ARTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; INCLUSION BODY MYOSITIS; LEUKOCYTOCLASTIC VASCULITIS; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYOSITIS; NEURITIS; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; PARAPROTEINEMIA; POLYARTERITIS NODOSA; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERODERMA; SEX RATIO; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33748966989     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0881-z     Document Type: Erratum

References (58)

1. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I (2003) Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 60(6):1024-1026
2. Arnason BG, Soliven B (1993) Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. WB, Saunders, Philadelphia, pp 1437-1497
3. Badrising UA, Maat-Schiemann M, van Duinen SG et al. (2000) Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 55:1385-1387
4. Busby M, Donaghy M (2003) Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 250:714-724
5. Cheng Q, Jiang GX, Fredrikson S (2000) Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol 7:11-16
6. Collins MP, Periquet MI (2004) Nonsystemic vasculitic neuropathy. Curr Opin Neurol 17:587-598
7. Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221-1231
8. Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17:561-567
9. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971-982
10. Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797-1810
11. Dyck PJ, Benstead TJ, Conn DL et al. (1987) Nonsystemic vasculitic neuropathy. Brain 110:843-853
12. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology (1997) A prospective study on the incidence and prognosis of Guillain-Barré syndrome in Emilia-Romagna region, Italy (1992-1993). Neurology 48:214-221
13. Flachenecker P, Zettl UK (2005) Epidemiologie. In: Schmidt RM, Hoffmann F (eds) Multiple Sklerose. Urban and Fischer, München, pp 9-15
14. Flachenecker P, Zettl UK, Götze U, Haas J, Schimrigk S, Elias W, Pette M, Eulitz M, Hennig M, Bertram J, Hollweck R, Neiss A, Daumer M, Pitschnau-Michel D, Rieckmann P (2005) MS-Register in Deutschland - Design und erste Ergebnisse der Pilot-phase. Nervenarzt 76:967-975
15. Govoni V, Granieri E (2001) Epidemiology of the Guillain-Barre syndrome. Curr Opin Neurol 14:605-613
16. Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT (2004) Guillain-Barre syndrome following influenza vaccination. JAMA 292:2478-2481
17. Hartung HP, Kieseier BC, Kiefer R (2001) Progress in Guillain- Barré syndrome. Curr Opin Neurol 14:597-604
18. Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome - Part I Muscle Nerve 18:137-153
19. Hein T, Hopfenmüller W (2000) Hochrechnung der Zahl an Multiple Sklerose erkrankten Patienten in Deutschland. Nervenarzt 71:288-294
20. Hohlfeld R, Wekerle H (1994) The thymus in myasthenia gravis. Neurol Clin 12:331-342
21. Hovi T, Stenvik M (2000) Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study. Bull World Health Organ 78:298-304
22. Hunder GG, Arend WP, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33:1065-1067
23. Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192
24. Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J (1997) Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-1993. J Neurol Neurosurg Psychiatry 62:447-453
25. Kaida K, Kusunoki S, Kamakura K et al. (2000) Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123:116-124
26. Keegan BM, Noseworthy JH (2002) Multiple sclerosis. Annu Rev Med 53:285-302
27. Kissel JT (2001) Vasculitic neuropathies. In: Gilman S (ed) MedLink Neurology. MedLink Corporation, San Diego
28. Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382-427
29. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT (1998) The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 339:1797-1802
30. Léger JM, Behin A (2005) Multifocal motor neuropathy. Curr Opin Neurol 18:567-573
31. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
32. Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 998:413-423
33. Martyn C (1991) The epidemiology of multiple sclerosis. In: Matthews WB (ed) McAlpines's multiple sclerosis. Churchill Livingstone, New York, pp 3-40
34. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 61:1373-1377
35. Meyer-Rienecker H, Buddenhagen F (1988) Incidence of multiple sclerosis: a periodic or stable phenomenon. J Neurol 235:241-244
36. Mygland A, Monstad P (2001) Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 8:157-165
37. Nobile-Orazio E (2004) IgM paraproteinaemic neuropathies. Curr Opin Neurol 17:599-605
38. Oldflors A, Lindberg C (2005) Diagnosis, pathogenesis and treatment of inclusion body myositis. Curr Opin Neurol 18:497-503
39. Olney RK, Lewis RA, Putnam TD, Campellone RV (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27:117-121
40. Palace J, Vincent A, Beeson D (2001) Myasthenia gravis: diagnostic and management dilemmas. Curr Opin Neurol 14:583-589
41. Phillips BA, Zilko PJ, Mastaglia FL (2000) Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve 23:970-972
42. Phillips LH (2004) The epidemiology of myasthenia gravis. Semin Neurol 24:17-20
43. Pinching AJ, Peters DK, Newsom Davis J (1976) Remission of myasthenia gravis following plasma exchange. Lancet 2:1373-1376
44. Poser CM (1994) The epidemiology of multiple sclerosis: a general overview. Ann Neurol 36(Suppl 2):S180-S193
45. Potagas C, Dellatolas G, Tavernarakis A, Molari H, Mourtzouhou P, Koutra H, Matikas N, Balakas N (2004) Myasthenia gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population. J Neurol 251:116-117
46. Rees JH, Soudain SE, Gregson NA, Hughes RA (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333:1374-1379
47. Saperstein DS, Katz JS, Amato AA, Barohn RJ (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311-324
48. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al. (1979) Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am J Epidemiol 110:105
49. Sommer C, Heuss D, Schlotter-Weigel B, Engelhardt A, Reinhold-Keller E (2003) Diagnostik und Therapie der vaskulitischen Neuropathien und Neuropathien bei Kollagenosen. In: Diener HC, für die Kommission "Leitlinien" der Deutschen Gesellschaft für Neurologie (eds) Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart New York, pp 263-273
50. Teixeira A, Cherin P, Demoule A et al. (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15:32-39
51. Toyka KV, Drachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397-399
52. van der Meulen MFG, Bonner M, Hoogendijk JE et al. (2003) Polymyositis: a diagnostic entity reconsidered. Neurology 61:316-321
53. van Doorn PA, Ruts L (2004) Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 17:607-613
54. van Koningsveld R, van Doorn PA, Schmitz PIM et al. (2000) Mild forms of Guillain-Barré syndrome in an epidemiological survey in the Netherlands. Neurology 54:620-625
55. Viala K, Renie T, Maisonobe T et al. (2004) Follow-up and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127:2010-2017
56. Voermans NC, Vaneker M, Hengstman GJ et al. (2004) Primary respiratory failure in inclusion body myositis. Neurology 63:2191-2192
57. Weinshenker BG, Bass B, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 112:133-146
58. Willison HJ, Veitch J, Paterson G, Kennedy PGE (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 56:204-206